VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HUMHumana Inc.
$360.65$43.3B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHUMPrice Target
HUM logo

Humana Inc. (HUM) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Hold
Based on 44 analysts

17.2% Above Target

HUM trades 17.2% above Wall Street's consensus target of $298.50.

Current Price$360.65
Average Target$298.50
Target
Current
Low$195.00
Median$264.50
High$441.00

Analyst Target Range

Forward P/E40.8x
(Growth Premium)
PEG Ratio—
Implied Growth-5.7%
(Declining)
Analyst Spread82.4%
(Wide Disagreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$360.65
Consensus$298.50
High$441.00
Low$195.00

Consensus Scenario Assumptions

The base valuation assumes HUM achieves its forward estimates and maintains a stable P/E multiple of 40.8x. This scenario reflects the blended consensus of 44 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 44 published analyst recommendations for HUM

64% hold / mixed conviction
+14
BearishBullish
Weighted analyst sentiment score based on 44 ratings
ConsensusHold
Coverage44 Analysts
Net Score+14
Bull / Bear32% / 5%
Strong Buy00%
Buy1432%
Hold2864%
Sell25%
Strong Sell00%
Strong Buy
00%
Buy
1432%
Hold
2864%
Sell
25%
Strong Sell
00%
Recommendation Mix32% Buy · 64% Hold · 5% Sell
Buy (14)Hold (28)Sell (2)

HUM Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, Humana Inc. (HUM) has a Wall Street consensus price target of $298.50, based on estimates from 44 covering analysts. With the stock currently trading at $360.65, this represents a potential downside of -17.2%. The company has a market capitalization of $43.30B.

Analyst price targets range from a low of $195.00 to a high of $441.00, representing a 82% spread in expectations. The median target of $264.50 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.

The current analyst consensus rating is Hold, with 14 analysts rating the stock as a Buy or Strong Buy,28 rating it Hold, and 2 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.

From a valuation perspective, HUM trades at a trailing P/E of 36.7x and forward P/E of 40.8x. Analysts expect EPS to grow -5.7% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $708.90, with bear and bull scenarios of $446.60 and $934.04 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+3.3%
Industry Consensus
Avg Forward P/E
43.8x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
UNH logo
UNHUnitedHealth Group Incorporated
$363.9B$400.96$425.81
+6.2%
Buy21.8x52
CVS logo
CVSCVS Health Corporation
$125.4B$98.32$103.64
+5.4%
Buy13.3x41
ELV logo
ELVElevance Health Inc.
$84.4B$388.50$415.19
+6.9%
Buy14.5x37
CNC logo
CNCCentene Corporation
$30.1B$61.02$59.00
-3.3%
Buy17.5x43
MOH logo
MOHMolina Healthcare, Inc.
$10.2B$195.37$175.55
-10.1%
Buy38.0x38
ALHC logo
ALHCAlignment Healthcare, Inc.
$4.5B$21.86$24.33
+11.3%
Buy118.7x16
OSCR logo
OSCROscar Health, Inc.
$7.4B$28.40$24.20
-14.8%
Hold31.5x11
CLOV logo
CLOVClover Health Investments, Corp.
$2.6B$5.00$4.47
-10.6%
Hold129.2x9
BHVN logo
BHVNBiohaven Ltd.
$1.4B$13.57$17.60
+29.7%
Buy—25
ACGL logo
ACGLArch Capital Group Ltd.
$32.5B$91.18$102.57
+12.5%
Buy9.8x34

HUM — Frequently Asked Questions

Quick answers to the most common questions about buying HUM stock.

What is the HUM stock price target for 2026?

HUM's consensus price target is $298.5, -17.2% below the current price of $360.65. The 44 analysts tracking HUM see downside risk at present valuations.

Is HUM a buy, sell, or hold?

HUM has a consensus rating of "Hold" based on 44 Wall Street analysts. The rating breakdown is mixed, with 28 Hold ratings making up the largest segment. The consensus 12-month price target of $298.5 implies -17.2% downside from current levels.

Is HUM stock overvalued or undervalued?

At a forward P/E of 40.846x, HUM trades at a premium valuation. The consensus price target of $298.5 (-17.2% downside) suggests analysts may view current valuations as stretched.

How high can HUM stock go?

The most bullish Wall Street analyst has a price target of $441 for HUM, while the most conservative target is $195. The consensus of $298.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $934 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover HUM stock?

HUM is heavily covered by Wall Street, with 44 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 28 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the HUM stock forecast?

The 12-month HUM stock forecast based on 44 Wall Street analysts shows a consensus price target of $298.5, with estimates ranging from $195 (bear case) to $441 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $709, with bear/bull scenarios of $447/$934.

What is HUM's fair value based on fundamentals?

Our quantitative valuation model calculates HUM's fair value at $709 (base case), with a bear case of $447 and bull case of $934. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.

What is HUM's forward P/E ratio?

HUM trades at a forward P/E ratio of 40.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 36.7x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy HUM stock?

Analysts are cautious on HUM, with 2 Sell ratings and a price target of $298.5 (-17.2% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do HUM price targets vary so much?

HUM analyst price targets range from $195 to $441, a 82% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $298.5 consensus represents the middle ground. Our model's $447-$934 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into HUM consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare